Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Apr, 15 2026
Mar, 5 2026
Jul, 10 2025
Dec, 15 2025
Feb, 9 2026